Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Synergy CHC Corp.SNYR · Entity 8555 | Director · President | June 29, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Synergy CHC Corp.
Report date June 29, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.21 · Expires 2030-09-18 | Direct | 150,000 |
Reported balance
After 2026-06-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-29 · Grant · Acquired 150,000 · Balance 150,000 F2: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date. F1: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.38 · Expires 2030-09-18 | Direct | 0 |
Reported balance
After 2026-06-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-29 · Disposition to issuer · Disposed 150,000 · Balance 0 F2: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date. F1: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.
F2: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2026 Filed Jul 1, 2026 20:40 UTC | Synergy CHC Corp. SNYR · Entity 8555 | Disposition to issuerStock Option (right to buy) · Derivative | 150,000 | Not disclosed Strike: $2.38 | Not disclosed |
DisclosureSEC source: 0001903189-26-000002 · primary_doc.xml · derivative · entry 2 Baumeler Alfred · CIK 0001903189 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.00001 per share · 150,000 shares Expires 2030-09-18 F2 · price: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date. F1 · derivative.exercise_date: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 20:40 UTC | Synergy CHC Corp. SNYR · Entity 8555 | GrantStock Option (right to buy) · Derivative | 150,000 | Not disclosed Strike: $0.21 | Not disclosed |
DisclosureSEC source: 0001903189-26-000002 · primary_doc.xml · derivative · entry 1 Baumeler Alfred · CIK 0001903189 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock, par value $0.00001 per share · 150,000 shares Expires 2030-09-18 F2 · price: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date. F1 · derivative.exercise_date: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company. Read SEC document |
| September 18, 2025 Filed Sep 23, 2025 01:31 UTC | Synergy CHC Corp. SNYR · Entity 8555 | GrantStock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001903189-25-000002 · primary_doc.xml · derivative · entry 1 Baumeler Alfred · CIK 0001903189 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock, par value $0.00001 per share · 150,000 shares Expires 2030-09-18 F1 · derivative.exercise_date: One-third (1/3) of this option grant vests on the first anniversary of the date of grant, and the remaining two-thirds (2/3) vest in equal monthly installments over the following twenty-four (24) months, subject to the reporting person's continued service with the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.